AHG (Akso Health Group) EBIT: $-4.82 Mil (TTM As of Sep. 2025)


AHG Akso Health Group AHG
36 GF Score
Price $1.52
GF Value $0.47
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Akso Health Group EBIT?

Akso Health Group AHG +10.14% 36 EBIT is $-4.82 Mil as of Sep. 2025. GuruFocus rates AHG with a GF Score™ of 36/100 and a GF Value™ of $0.47 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Akso Health Group's earnings before interest and taxes (EBIT) for the six months ended in Sep. 2025 was $-1.44 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2025 was $-4.82 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Akso Health Group's annualized ROC % for the quarter that ended in Sep. 2025 was -2.19%. Akso Health Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2025 was -3.27%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Akso Health Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2025 was -0.37%.

Akso Health Group  (NAS:AHG) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Akso Health Group's annualized ROC % for the quarter that ended in Sep. 2025 is calculated as:

ROC % (Q: Sep. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Mar. 2025 ) + Invested Capital (Q: Sep. 2025 ))/ count )
=-2.874 * ( 1 - 9.65% )/( (35.167 + 201.686)/ 2 )
=-2.596659/118.4265
=-2.19 %

where

Invested Capital(Q: Mar. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=214.953 - 3.556 - ( 176.23 - max(0, 13.813 - 196.125+176.23))
=35.167

Invested Capital(Q: Sep. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=212.043 - 3.985 - ( 11.129 - max(0, 12.016 - 18.388+11.129))
=201.686

Note: The Operating Income data used here is two times the semi-annual (Sep. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Akso Health Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Sep. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Mar. 2025  Q: Sep. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-2.874/( ( (0.115 + max(-5.82, 0)) + (175.759 + max(-7.412, 0)) )/ 2 )
=-2.874/( ( 0.115 + 175.759 )/ 2 )
=-2.874/87.937
=-3.27 %

where Working Capital is:

Working Capital(Q: Mar. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.954 + 0.19 + 6.809) - (3.556 + 10.217 + 0)
=-5.82

Working Capital(Q: Sep. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(3.17 + 0.194 + 1.198) - (3.985 + 7.989 + 0)
=-7.412

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Sep. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Akso Health Group's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Sep. 2025 )
=-4.819/1291.131
=-0.37 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Akso Health Group EBIT Related Terms

Akso Health Group EBIT Historical Data

* Premium members only.

The historical data trend for Akso Health Group's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Akso Health Group EBIT Chart

Akso Health Group Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.14 -3.20 -14.27 -8.64 -3.92

Akso Health Group Semi-Annual Data
Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.32 -6.32 -0.54 -3.38 -1.44

AHG vs ACH, EDAP, YI: EBIT Comparison

For the Medical Distribution subindustry, Akso Health Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Akso Health Group EV-to-EBIT vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Akso Health Group's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Akso Health Group's EV-to-EBIT falls into.


AHG
36GF Score
Akso Health Group AHG
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Akso Health Group EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-4.82 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $-4.82 Mil mean?
Akso Health Group (AHG) has a EBIT of $-4.82 Mil as of Sep. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Akso Health Group.
Is Akso Health Group's EBIT too high?
Akso Health Group's current EBIT is $-4.82 Mil. Overall, Akso Health Group has a GF Score™ of 36/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Akso Health Group's EBIT compare to ACH and EDAP?
Akso Health Group's EBIT of $-4.82 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Distribution company?
A good EBIT depends on the Medical Distribution industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Akso Health Group. Akso Health Group's current EBIT is $-4.82 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Akso Health Group stock overvalued right now?
Based on GuruFocus' analysis, Akso Health Group (AHG) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.47, compared to a current price of $1.52 — trading 223.4% above its estimated fair value. The current EBIT is $-4.82 Mil. Akso Health Group's overall GF Score™ is 36/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Akso Health Group (AHG), the current EBIT is $-4.82 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Akso Health Group (AHG) Overvalued in 2026?

Based on GuruFocus' analysis, Akso Health Group stock appears to be overvalued. The current stock price of $1.52 is trading 223.4% above its estimated GF Value™ of $0.47. GuruFocus considers Akso Health Group to be Significantly Overvalued.

Key valuation signals for AHG:

  • EBIT: $-4.82 Mil
  • GF Value™: $0.47 vs. price of $1.52 (223.4% above fair value)
  • GF Score™: 36/100 with 2 warning signs

No single metric tells the full story. See the AHG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Akso Health Group Business Description

Address No. 44, Moscow Road, Qianwan Bonded Port Area, Room 8201-4-4(A), 2nd Floor, Qiantongyuan Building, Qingdao Pilot Free Trade Zone, Shandong, CHN
Akso Health Group is a social e-commerce platform based in China. The company collaborates with domestic e-commerce platforms and offers users a wide selection of high-quality and affordable products on its social e-commerce platform. It generates majority of the revenues from sale of medical devices business.
36GF Score

Get the complete analysis for AHG

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.52
Price
$0.47
GF Value